Diagnostics & Healthcare News

Medical device manufacturer Animas, a subsidiary of Johnson & Johnson, is warning diabetic patients who use its OneTouch Ping insulin pumps about security issues that could allow hackers to deliver unauthorized doses of insulin.  The vulnerabilities were discovered by Jay Radcliffe, a security researcher at Rapid7 who is a Type I diabetic and user of…

Researchers from University of Pittsburgh and University of Pittsburgh Medical Center (UPMC), successfully managed to bring back the feeling of sensation to a man severely paralyzed a decade earlier. The 28 year-old had electrodes from a brain-computer interface (BCI) implanted into the primary somatosensory cortex of his brain. The BCI was connected to a robotic arm with built-in…

Ex-Stryker rep, Chris Ridgeway, has been in the middle of a legal battle with Stryker since September 2013 when they fired and sued him, claiming he conspired with Biomet to steal Stryker’s trade secrets, pricing, and obtain a distributorship deal through Ridgeway’s side business, Stone Surgical, LLC. Ridgeway has since filed bankruptcy protection in an effort to not…

The Food and Drug Administration’s approval of a new insulin delivery system for people with Type 1 diabetes is a big deal. With Type 1 diabetes, the pancreas makes little or no insulin so people have to replace it with either multiple daily injections or a pump. In either case, that process involves constant error-prone…

Elizabeth Holmes, the embattled founder and chief executive of Theranos, said late Wednesday that the company will close its clinical labs and Walgreens testing centers. The open letter, posted on the company’s website, was essentially an epitaph for the consumer-facing business that was the focus of the once-celebrated Silicon Valley company that Holmes boasted would…

BrainScope — a medtech specializing in traumatic brain injury (TBI) diagnostic technology that is backed by the U.S. Department of Defense (DOD)— has announced FDA clearance for Ahead 300, a hand-held medical device capable of objectively assessing the likelihood of TBI. The technology leverages advanced algorithms and machine learning to diagnose the “full spectrum” of…

While kidney stones are not the cause of death they were in generations past, helping them pass through the urinary tract can still be a challenge and involve a good amount of pain. What if instead the prescribed therapy was a trip to Disney World? Michigan State University urologist David Warninger, a Doctor of Osteopathic Medicine…

Patrick Paumen doesn’t have to worry about forgetting his keys and being locked out of his apartment. That is because he doesn’t need a key anymore—he simply unlocks the door with a wave of his hand. The 32-year-old IT expert from the Dutch city of Heerlen is one of a growing number of people with…

The drug company that makes the EpiPen says it isn’t nearly as profitable as many people assume it is. At least that’s the message Mylan NV CEO Heather Bresch will try to deliver to members of Congress today. Bresch, who is scheduled to testify before the House Oversight and Government Reform Committee, is expected to…

When U.S. medtech companies acquire European firms, the deals tend to be worth much more than those of European firms taking over American concerns. That’s according to a report by EP Vantage, which chalked the imbalance up to the fact that Europeanmedtech companies are generally smaller and less well-funded than their U.S. counterparts. Excluding Medtronic’s $50…